The study supports risk-based regulatory approaches, emphasizing realistic exposure scenarios for PFAS in textiles.
Chromatography industry faces AI adoption challenges, workforce issues, and budget constraints, with biopharmaceutical sectors showing career growth. Peptide science is revolutionized by GLP-1 drugs, ...
The Agilent 6470 Triple Quadrupole LC/MS system is at the forefront of robustness, reliability and accuracy, which makes it a perfect option for many applications, including peptide quantitation, food ...
Paulick Report on MSN
Owner/Trainer Summarily Suspended After Novel Drug Found In Racing Quarter Horse
This is believed to be the first U.S. positive for tulobuterol, a drug from the same family as clenbuterol and albuterol.
Repeated insulin shots at the same site can seed amyloid; consider this diagnosis if absorption seems erratic or glucose control worsens with a persistent lump.
Study Finds on MSN
Everyday Chemicals Triple Teen Risk of Liver Disease
PFOAS, or forever chemicals, are everywhere nowadays. Exposure is unavoidable, but teens appear especially vulnerable ...
A new study reveals that roasted coffee contains previously unknown compounds capable of inhibiting a key enzyme linked to blood sugar control. Scientists have identified three compounds that strongly ...
Endophytic fungus from from Madagascar periwinkle offers a greener, cheaper way to produce the cancer drug vinblastine.
The Prima PRO and Sentinel PRO mass spectrometers from Thermo Scientific enhance both process efficiency and workplace safety, transforming gas analysis.
Learn more about whether Agilent Technologies, Inc. or Charles River Laboratories International, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...
Moses Mayonu, a Ghanaian scientist, is making significant strides in global biomedical research, emerging as one of the ...
In addition, Der Simulierte Mensch (Si-M), The Simulated Human, a new research center, is being finalized in Berlin to open in 2026. Neubauer explains this is a joint partnership between TU Berlin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results